Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Vaccine Therapy in Treating Patients With Stage IV Melanoma

ClinicalTrials.gov ID: NCT00042783

Public ClinicalTrials.gov record NCT00042783. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 3, 2026, 4:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Trial Of A D1/3-MAGE3-HIS Fusion Protein (NSC-719274) With Adjuvant SBAS02B (NSC-719275) For Patients With Stage IV, M1a or M1b Metastatic Melanoma

Study identification

NCT ID
NCT00042783
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
SWOG Cancer Research Network
Network
Enrollment
Not listed

Conditions and interventions

Interventions

  • D1/3-MAGE-3-His fusion protein Biological
  • SB-AS02B adjuvant Biological

Biological

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2002
Primary completion
Not listed
Completion
Feb 28, 2006
Last update posted
Jun 23, 2013

2002 – 2006

United States locations

U.S. sites
7
U.S. states
6
U.S. cities
6
Facility City State ZIP Site status
Arizona Cancer Center at University of Arizona Health Sciences Center Tucson Arizona 85724
USC/Norris Comprehensive Cancer Center and Hospital Los Angeles California 90033
Jonsson Comprehensive Cancer Center, UCLA Los Angeles California 90095-1781
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201-1379
Veterans Affairs Medical Center - Biloxi Biloxi Mississippi 39531-2410
CCOP - Columbia River Oncology Program Portland Oregon 97225
University of Washington School of Medicine Seattle Washington 98195-6527

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00042783, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2013 · Synced May 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00042783 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →